home / stock / invvy / invvy quote
Last: | $21.8455 |
---|---|
Change Percent: | 0.89% |
Open: | $21.65 |
Close: | $21.8455 |
High: | $21.8455 |
Low: | $21.64 |
Volume: | 8,103 |
Last Trade Date Time: | 06/09/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$21.8455 | $21.65 | $21.8455 | $21.8455 | $21.64 | 8,103 | 06-09-2023 |
$22.25 | $23.06 | $22.25 | $23.06 | $21.51 | 1,448 | 06-08-2023 |
$22.1 | $21.9 | $22.1 | $22.5 | $21.9 | 3,270 | 06-07-2023 |
$21.95 | $22.2 | $21.95 | $22.3 | $21.95 | 3,003 | 06-06-2023 |
$22.21 | $23 | $22.21 | $23.11 | $22.21 | 1,877 | 06-05-2023 |
$22.02 | $20.7 | $22.02 | $22.02 | $20.51 | 5,158 | 06-02-2023 |
$20.9 | $21.5 | $20.9 | $21.99 | $20.21 | 5,788 | 06-01-2023 |
$22.5 | $24.183 | $22.5 | $24.183 | $21.65 | 2,584 | 05-31-2023 |
$23.3 | $23.82 | $23.3 | $23.892 | $23.25 | 4,111 | 05-30-2023 |
$22.69 | $25 | $22.69 | $25 | $22.69 | 6,506 | 05-29-2023 |
$22.69 | $25 | $22.69 | $25 | $22.69 | 6,506 | 05-26-2023 |
$24.114 | $23.65 | $24.114 | $24.99 | $23.22 | 4,140 | 05-25-2023 |
$23.9 | $27 | $23.9 | $27 | $23.6499 | 13,910 | 05-24-2023 |
$25.95 | $27.25 | $25.95 | $28.9 | $25.75 | 8,998 | 05-23-2023 |
$25.95 | $29.4 | $25.95 | $29.4 | $23.7 | 4,048 | 05-22-2023 |
$29.47 | $23.56 | $29.47 | $29.47 | $23.56 | 7,187 | 05-19-2023 |
$21.41 | $0 | $21.41 | $0 | $0 | 313 | 05-18-2023 |
$21.41 | $24.15 | $21.41 | $24.15 | $21.41 | 2,266 | 05-17-2023 |
$23 | $25.6888 | $23 | $25.6888 | $23 | 2,886 | 05-16-2023 |
$26.45 | $26.7825 | $26.45 | $26.7825 | $26.45 | 1,028 | 05-15-2023 |
News, Short Squeeze, Breakout and More Instantly...
Indivior PLC ADR Company Name:
INVVY Stock Symbol:
OTCMKTS Market:
Indivior Announces Q1 2024 Financial Results PR Newswire SLOUGH, United Kingdom and RICHMOND, Va. , April 25, 2024 /PRNewswire/ -- Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024 . The earnings re...
Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone PR Newswire This head-to-head pharmacodynamic study in healthy volunteers...
Court Provides Final Approval of Settlement with Direct Purchaser Class in the Multidistrict Antitrust Litigation; Final Court Approval Concludes the Antitrust Multidistrict Litigation PR Newswire RICHMOND, Va. , Feb. 29, 2024 /PRNewswire/ -- Indivior PLC (LSE: I...